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httpcense.Abstract Objectives: Adherence to therapy is very important and many factors could be respon-
sible for this issue. Suboptimal adherence to asthma therapy is a major contributor to poor asthma
outcomes. Our aim is to ﬁnd out the most important factor responsible for adherence to therapy in
bronchial asthma patients.
Subjects and methods: The study included 143 patients with persistent bronchial asthma. Factors
that may affect adherence to therapy were studied. These factors included age, sex, residence, level
of education, proper asthma education and whether inhaled corticosteroid (ICS) was taken alone,
with long acting b2 agonist (LABA) in separate devices or with LABA in a combined form. Adher-
ence to ICS was determined according to Medication Rating Scale.
Results: We found that 55.3% of patients that received asthma education were adherent to ICS
while only 21% of patients that did not receive asthma education were adherent to ICS therapy.
The difference was statistically highly signiﬁcant (p= 0.003). Other factors do not signiﬁcantly
affect adherence to ICS. Patients that used combined ICS with LABA in the same device were sig-
niﬁcantly more adherent to therapy (60.25%) than patients that used the same combination in 2
separate devices (34.5%). All patients with well controlled asthma were adherent to ICS, while
47.5% of uncontrolled patients was adherent. Comparison between level of control and adherence
to ICS was highly signiﬁcant (p= 0.003).
Conclusion: This study showed how different factors may modulate adherence to asthma treat-
ment and conﬁrmed the importance of patient education in increasing adherence to asthma therapy.
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Adherence to (or compliance with) a medication regimen is gen-
erally deﬁned as the extent to which patients takemedications as
prescribed by their health care providers. Theword ‘‘adherence’’
is preferred by many health care providers, because ‘‘compli-
ance’’ suggests that the patient is passively following the doc-
tor’s orders and that the treatment plan is not based on a
therapeutic alliance or contact established between the patient
and the physician. Both terms are imperfect and uninformativeis. Production and hosting by Elsevier B.V.
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372 N. Rifaat et al.descriptions of medication-taking behavior. Unfortunately,
applying these terms to patients who do not consume every pill
at the desired time can stigmatize these patients in their future
relationships with health care providers. The language used to
describe how patients take their medications needs to be
reassessed, but these terms are still commonly used [1].
Asthma is a signiﬁcant public health problem, particularly
among inner city populations. It is a leading cause of prevent-
able emergency room visits and hospitalizations. Considerable
efforts have been directed at promoting appropriate self-man-
agement behaviors in order to improve asthma outcomes [2].
The ﬁrst difﬁculty is to explain to the patient that asthma is a
chronic disease and has a wide margin of variability [3]. In a
great number of cases the patients do not perceive the chronic
nature of their illness, its long term outcome and the signiﬁcance
of long-term therapy. The real problem for the management of
asthma is the adherence to treatment and self – management [4].
It has been estimated that the regular use of inhaled corti-
costeroid (ICS) could reduce asthma hospitalizations by as
much as 80%, and that the risk of death from asthma de-
creases by 21% for each additional ICS canister used in the
previous year [5]. Despite such potential, patients with asthma
appear to adhere poorly to prescribed ICS medications [6].
There have been many delivery systems developed for ICS,
each with advantages and disadvantages. Among these, the
two most frequently used devices are the pressurized metered
dose inhaler and the dry powder inhaler. For ICS to be effec-
tive, good inhaler technique and adequate adherence are
important. With regard to technique, speciﬁc steps and good
coordination are necessary for the proper use of these devices.
A less than optimal technique can result in decreased drug
delivery and potentially reduced efﬁcacy [7].
Patient education, pulmonary function monitoring, envi-
ronmental control and pharmacotherapy are four main pillars
of asthma management [8]. Because of its several advantages,
inhalation therapy has become the treatment of ﬁrst choice
in the western countries, though deﬁciencies exist there also.
Studies of adults and children have shown compliance rates
of around 50% with the taking of regular preventive therapy
(around 35% in USA and 41% in Europe) [9].
Adherence to therapies is a primary determinant of treat-
ment success. Poor adherence attenuates optimum clinical ben-
eﬁts and therefore reduces the overall effectiveness of health
systems, yet it is estimated that in developed countries, only
50% of patients who suffer from chronic diseases adhere to
treatment recommendations [10]. Coordinating multiple com-
ponents of the healthcare system is necessary to improve
adherence and clinical outcomes. For instance, psychological
problems such as depression and anxiety disorders are com-
mon among asthma patients and their primary caregivers,
and may present signiﬁcant barriers to adherence [11].
Although collaborative efforts to improve adherence may
be costly in the short run, the long-term cost savings gained
by improved adherence can exceed the cost of adherence pro-
motion. This makes adherence promotion a worthy ‘‘invest-
ment’’ in managing asthma outcomes [12].
Asthma education is an essential part of the treatment of
this disease. Health care professionals must establish a partner-
ship with the patient with asthma and the patient’s family to
devise a plan of care with which the patient voluntarily will
comply. When the partnership is based on mutual trust and
cooperation, the clinician can direct asthma care that is consis-tent with current expert guidelines. Educational interventions
should be meaningful to the patient, considering patient’s
needs, and sensitive to the patient’s cultural inﬂuences [13].
Subjects and method
One hundred and forty-three asthmatics that attended the out-
patient clinic in El Minia and Assiut University hospitals were
included. Enrolled patients were under treatment with ICS
either alone or combined with LABA. Complete medical his-
tory was taken every visit in order to determine the level of con-
trol according to the control level in GINA guidelines. Factors
that may affect adherence to therapy were studied. These fac-
tors included age, sex, residence, level of education, proper
asthma education and whether ICS was used alone, with LABA
in separate devices or with LABA in a combined form. One
hundred and twelve asthmatic patients attended the asthma
education program sessions. Duration of asthma education
program was 2 months and its basic components included the
basics of asthma, diagnosis of asthma, types of treatment avail-
able, advantages of inhalation therapy, role of ‘relievers’ and
‘preventers’, removing misconceptions. The rest of the patients
[31] were prescribed inhalers by other centers and by assessing
the educational programs they got we reached the conclusion
that some patients did not get education at all and the others
got insufﬁcient education.
Basic components of asthma education program [14]
 Basics of asthma
- Asthma is a fully controllable ailment, though not curable
as yet.
- Airway inﬂammation is the main defect in asthma.
- Steroid inhalers, taken regularly with proper technique are
best tools to tackle this inﬂammation.
- Regular drug intake curtails the cost of therapy and pro-
gression of the disease.
- All these aspects should be covered in simple language cit-
ing common examples.
 Diagnosis of asthma.
 Types of treatment available.
 Advantages of inhalation therapy.
 Role of ‘relievers’ and ‘preventers’.
 Removing misconceptions: Patients may believe misconcep-
tions about inhalation therapy that inhalation therapy may
be dangerous and damage lungs and heart, must be the last
resort, habit forming, higher cost and difﬁcult to use in
addition to steroid phobia which is present in most patients.
 Trigger avoidance (including drugs).
 Monitoring of asthma.
 Crisis recognition and management.
 Adopting a healthy life style.
 Patients should be motivated for adopting a healthy life
style including smoking cessation, well-balanced diet, regu-
lar exercise and the avoidance of obesity.
Treatment checked repeatedly as incorrect use of inhalation
devices is frequently observed at all levels. Misconceptions
about asthma and its management, especially inhalation ther-
Table 1 Items of the Modiﬁed Morisky Scale [15].
Items Response
format
Do you sometimes forget to take
your [health concern] pills?
Yes or
No
People sometimes miss taking their
medications for reasons other than
forgetting. Thinking over the past
two weeks, were there any days when
you did not take your [health
concern] medicine?
Yes or
No
When you travel or leave home, do
you sometimes forget to bring along
your [health concern] medication?
Yes or
No
Did you take your [health concern]
medicine yesterday?
Yes or
No
When you feel like your [health
concern] is under control, do you
sometimes stop taking your
medicine?
Yes or
No
Taking medication every day is a real
inconvenience for some people. Do
you ever feel hassled about sticking to
your [health concern] treatment plan?
Yes or
No
How often do you have diﬃculty
remembering to take all your
medications?
Never/
Rarely,
Once in a
while,
Sometimes, Usually, All the time
The Modiﬁed Morisky scale yield a total score with a range of 0–7,
with higher scores indicating higher adherence to medication. The
scores of the Modiﬁed Morisky scale can be categorized as low
compliers (<6), medium compliers (=6) and high compliers (=7).
Table 2 Sociodemographic data of the studied asthmatic
patients.
Sociodemographic data N (%)
Sex
Male 40 (28)
Female 103 (72)
Residence
Urban 79 (55.2)
Rural 64 (44.8)
Level of education
University 62 (43.3)
Basic and secondary 24 (16.8)
Illiterate or read and write only 57 (39.9)
Control level
Controlled 10 (7)
Partially controlled 93 (65)
Uncontrolled 40 (28)
Adherence to ICS
Adherent 70 (49)
Not adherent 73 (51)
Patient education
Present 112 (78.3)
Absent 31 (21.7)
Age (mean ± SD) years 44.3 ± 14.648
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booklets, charts, and inhalation devices to explain how to
use the devise. To determine adherence in asthmatic patients
we use the Modiﬁed Morisky Scale (MMS) (Table 1).
We asked the patient each question and circle the corre-
sponding ‘‘yes’’ or ‘‘no’’ response. The Modiﬁed Morisky scale
yields a total score with a range of 0–7, with higher scores indi-
cating higher adherence to medication. The scores of the Mod-
iﬁed Morisky scale can be categorized as low compliers (<6),
medium compliers (=6) and high compliers (=7) [15].
Statistical analysis
Quantitative data were expressed as mean and standard devi-
ation (mean ± SD). Student’s ‘‘t’’ test was used to compare
mean values of the two groups. Comparison between more
than 2 groups was performed by using one way ANOVA test
for parametric variables. Simple Pearson’s correlation coefﬁ-
cient was calculated to quantify the correlation between con-
tinuous variables and multiple stepwise regressions and was
used to determine the variables that may correlate indepen-
dently with Z-score BUA values. Statistical analysis was per-
formed using (SPSS) 16 for Windows software.
Results
Sociodemographic data of the studied asthmatic patients were
shown in Table 2. Comparison between adherent and nonadherent patients showed that adherent patients were signiﬁ-
cantly older than non adherent. Other factors namely, sex, res-
idence, and level of education showed no signiﬁcant difference
(Table 3). Table 4 showed that 55.3% of patients who received
education were adherent to ICS while only 21% of patients
who did not receive education were adherent to ICS therapy.
The difference was statistically highly signiﬁcant (p= 0.003).
Table 5 showed a relation between methods of administration
of ICS and adherence to treatment where more patients used
combined ICS with LABA in the same device (group1) adher-
ent to therapy (60.25%) than patients who used the same drugs
in 2 separate devices (34.2%) (group 2) and patients who re-
ceived ICS plus oral LABA (37.2%) (group 3). Table 6 showed
the relation between the level of asthma control and adherence
to treatment where 100% of well controlled patients were
adherent to ICS, while 44.1% of partial controlled patients
were adherent and 47.5% of uncontrolled patients were adher-
ent. Comparison between level of control and adherence to
ICS was highly signiﬁcant (p value = 0.003).
Discussion
Adherence to treatment is an important part in treatment suc-
cess. Adherence to ICS in asthmatic patients is a well docu-
mented issue in controlling the disease. In this study we
compared factors that affect adherence to ICS in asthmatic pa-
tients and try to explain the most important factor that affects
adherence. In our study adherence to asthma treatment was
49%. This result agreed with the observation of WHO which
recorded that treatment compliance in chronic diseases was
50% [10]. In his study, Lacasse et al. 2005 [16] showed that
compliance was 20–70%. In the other hand Al-Jabdali et al.
2007 [17] showed that compliance in their study was
Table 4 Effect of patient education on adherence to ICS in asthmatic patients.
Adherence to ICS Patient education p Value
With patient education Without patient education
Adherent, N (%) 62 (55.3%) 8 (21%) 0.003*
Not adherent, N (%) 50 (44.7%) 23 (79%)
Total, N (%) 112 (100%) 31 (100%)
* p Value <0.05.
Table 5 Comparison between methods of ICS administration and adherence to therapy.
Methods of ICS administration Adherence to ICS p Value
Adherent (No = 70) Not adherent (No = 73)
Group 1: (78, 100%)
Patients used ICS and LABA in the same device
47 (60.25%) 31 (39.75%) 0.001
Group 2: (38,100%)
Patients used ICS and LABA in 2 separate devices
13 (34.2%) 25 (65.8%)
Group 3: (27,100%)
patients used ICS alone or plus oral LABA
10 (37%) 17 (63%)
Table 6 Relation between control level of asthmatic patients adherence to ICS.
Adherence to ICS Control level p Value
Uncontrolled
N (%)
Partial controlled
N (%)
Well controlled
N (%)
Adherent 19 (47.5%) 41 (44.1%) 10 (100%) 0.003*
Not adherent 21 (52.5%) 52 (55.9%) 0
Total 40 (100%) 93 (100%) 10 (100%)
* p Value <0.05.
Table 3 Relation between sociodemographic factors of asthmatic patients and adherence to ICS.
Patients not adherent to ICS (N= 70)
N (%)
Patient adherent to ICS (N= 73)
N (%)
p Value
Sex
Male (N= 40) 24 (60%) 16 (40%) 0.1
Female(N= 103) 46 (44.6%) 57 (55.4%)
Residence
Urban (N= 79) 43 (54.4%) 36 (45.6%) 0.1
Rural (N= 64) 27 (42.2%) 37 (57.8%)
Level of education
University (N= 62) 30 (48.4%) 32 (51.6%) 0.66
Basic and secondary (N= 24) 10 (41.7%) 14 (58.3%)
Illiterate and (read and write) (N= 57) 30 (2.6%) 27 (47.4%)
Age (mean ± SD) years 47.2 ± 13.642 41.6 ± 15.5 0.02*
* p Value <0.05.
374 N. Rifaat et al.reasonably high (62%), which may be a reﬂection of the fact
that most of their patients has signiﬁcant asthma and followed
up in tertiary centers rather than primary centers.
In our study, patient gender did not affect treatment adher-
ence as the difference between male and female adherence wasstatistically not signiﬁcant. The results of many studies dis-
cussed this issue were contradictory. Female patients were
found by some researchers to have better compliance [18] while
some studies suggested otherwise [19]. In addition, some stud-
ies could not ﬁnd a relationship between gender and compli-
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compliance that concluded that gender has not been found to
inﬂuence compliance [21]. Gender may not be a good predictor
of non-compliance because of inconsistent conclusions.
For a long time it was believed that the level of education of
the patients is an important factor that affects adherence, sur-
prisingly our study showed that the level of education did not
affect adherence to ICS and was statistically insigniﬁcant. Sev-
eral studies found that patients with higher educational level
might have higher compliance [22,23], while some studies
found no association [24]. Intuitively, it may be expected that
patients with higher educational level should have better
knowledge about the disease and therapy and therefore be
more compliant. However, DiMatteo found that even highly
educated patients may not understand their conditions or be-
lieve in the beneﬁts of being compliant to their medication reg-
imen [25]. Other researchers showed that patients with lower
education level have better compliance [20]. Patients with low-
er educational level might have more trust in physicians’ ad-
vice. From these results, it seems that educational level may
not be a good predictor of therapeutic compliance.
This study showed that older patients tended to be more
adherent to prescribed asthma medications than younger ones.
We showed that older people might have more concern about
their health than younger patients, so that older patients’ non-
compliance is non-intentional in most cases. As a result, if they
can get the necessary help from healthcare providers or family
members, theymay bemore likely to be compliantwith therapies.
Some studies showed that older patients adhered more to
treatment regimens than younger patients. However, a different
outcome was seen in a different study where limited physical
ability of elderly patients reduced adherence level. This limita-
tionwas due to social isolation, auditory and visual impairment,
and health problems occurring among those taking a number of
medications for different medical conditions [26].
In our study, asthma education signiﬁcantly inﬂuences
adherence to ICS therapy and the difference was statistically
highly signiﬁcant between patients that received asthma educa-
tion and patients that did not receive this education. Rubin
found that educating the patients about their diseased state
and general comprehension of medications would increase
their active participation in treatment [27]. Making sure pa-
tients understand the drug dosing regimen could also improve
compliance. To make sure patients remember what was taught,
written instructions work better than verbal ones, as patients
often forget physician’s advice and statements easily [28].
The result of the study of Al-Jahdali et al. 2007 raises the
importance of the education program of the patient involved
in asthma care to discuss with them the role of asthma medica-
tions, particularly ICS, and to correct common fears and mis-
conceptions. Among the most common fears hindering regular
ICS use was their potential to lead to addiction (60%) and
worry from steroid side effects (41%) [17].
The simplicity of drug administration greatly increases adher-
ence as the complexity signiﬁcantly hinders it. If 2 or 3 different
medications are prescribed with 2 or 3 different delivery methods
(e.g. concurrent use of MDI andDPI) it may add to confusion in
techniques and lead to poor adherence. In our study patients that
received combined ICS and LABA in the same device (group1)
were signiﬁcantly more adherent to therapy than patients
that used combined ICS and LABA in two separate devices
(group2) and patients that used ICS plus oral LABA (group3).Increasing dosing and frequency in asthma treatment was
found to have an inverse correlation with adherence, as seen
in a study that was conducted on 14 children with asthma,
where inhaler compliance with twice, thrice- and four-times
daily dosing was examined. The compliance rate was 71, 34
and 18 percent respectively. Hence, increase of complication
in dosing regimen resulted in less compliant patients [29].
Medications with a convenient way of administration (e.g.
oral medication) are likely to make patients compliant. Studies
in asthma patients compared compliance between oral and in-
haled asthmamedications, and found patients had better compli-
ance with oral medication. Likewise, difﬁculty in using inhalers
contributes to non-compliance in patients with asthma [30].
Complex treatment is believed to threaten the patient’s com-
pliance. However, compliance does not seem to correlate with
the number of drugs prescribed but the number of dosing times
every day of all prescribed medications [29]. The rate of compli-
ance decreased as the number of daily doses increased. This is
illustrated by one study where compliance was assessed by pill
counts and self-reports that showed that non-compliance in-
creased with an increase in the frequency of prescribed dosing:
20% for once daily; 30% for twice daily; 60% for three times a
day; and 70%for four times daily [31]. Thus, simplifying themed-
ication dosing frequency could improve compliance markedly.
Achieving asthma control is central in optimizing patient
quality of life and clinical outcome. This study showed that
adherence to ICS therapy increases signiﬁcantly the control le-
vel of asthma symptoms and offers more improvement of pul-
monary function. The study of Al-Jabdali et al. 2007 reports
that misconception of the role of ICS and fear of untoward
side effects may reduce compliance to therapy, potentially
resulting in poor asthma control and outcome and increased
risk of severe asthma [17].
Conclusion
Among different factors that may modulate adherence to
treatment in asthmatic patients, asthma education is the most
important and golden factor in increasing adherence to ICS
therapy.
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